Campbell JL J, Clewell RA, Gentry PR, Andersen ME, Clewell HJ 3rd. Physiologically based pharmacokinetic/toxicokinetic modeling. Computational Toxicology, Methods in Molecular Biology Series. Methods in Molecular Biology 929. 2012: 439–499. ISBN 978-1-62703-049-6. PMID 23007440. doi:10.1007/978-1-62703-050-2_18.温哥华格式错误 (帮助)
Jeong, Yoo-Seong; Yim, Chang-Soon; Ryu, Heon-Min; Noh, Chi-Kyoung; Song, Yoo-Kyung; Chung, Suk-Jae. Estimation of the minimum permeability coefficient in rats for perfusion-limited tissue distribution in whole-body physiologically-based pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics. 2017, 115: 1–17. PMID 28215648. S2CID 3455193. doi:10.1016/j.ejpb.2017.01.026.
Darwich, AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. Journal of Pharmacy and Pharmacology. 2012, 64 (7): 1008–1024. PMID 22686346. S2CID 46066754. doi:10.1111/j.2042-7158.2012.01538.x.
Bouvier d'Yvoire, M.; Prieto P.; Blaauboer B.J.; Bois F.; Boobis A.; Brochot C.; Coecke S.; Freidig A.; Gundert-Remy U.; Hartung T.; Jacobs M. N. Physiologically-based kinetic modelling (PBK modelling): meeting the 3Rs agenda - The report and recommendations of ECVAM Workshop 63a. Alternatives to Laboratory Animals. 2007, 35 (6): 661–671. PMID 18186671. S2CID 1247463. doi:10.1177/026119290703500606.|author9=和|last9=只需其一 (帮助)
Campbell JL J, Clewell RA, Gentry PR, Andersen ME, Clewell HJ 3rd. Physiologically based pharmacokinetic/toxicokinetic modeling. Computational Toxicology, Methods in Molecular Biology Series. Methods in Molecular Biology 929. 2012: 439–499. ISBN 978-1-62703-049-6. PMID 23007440. doi:10.1007/978-1-62703-050-2_18.温哥华格式错误 (帮助)
Jeong, Yoo-Seong; Yim, Chang-Soon; Ryu, Heon-Min; Noh, Chi-Kyoung; Song, Yoo-Kyung; Chung, Suk-Jae. Estimation of the minimum permeability coefficient in rats for perfusion-limited tissue distribution in whole-body physiologically-based pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics. 2017, 115: 1–17. PMID 28215648. S2CID 3455193. doi:10.1016/j.ejpb.2017.01.026.
Darwich, AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. Journal of Pharmacy and Pharmacology. 2012, 64 (7): 1008–1024. PMID 22686346. S2CID 46066754. doi:10.1111/j.2042-7158.2012.01538.x.
Bouvier d'Yvoire, M.; Prieto P.; Blaauboer B.J.; Bois F.; Boobis A.; Brochot C.; Coecke S.; Freidig A.; Gundert-Remy U.; Hartung T.; Jacobs M. N. Physiologically-based kinetic modelling (PBK modelling): meeting the 3Rs agenda - The report and recommendations of ECVAM Workshop 63a. Alternatives to Laboratory Animals. 2007, 35 (6): 661–671. PMID 18186671. S2CID 1247463. doi:10.1177/026119290703500606.|author9=和|last9=只需其一 (帮助)
Jeong, Yoo-Seong; Yim, Chang-Soon; Ryu, Heon-Min; Noh, Chi-Kyoung; Song, Yoo-Kyung; Chung, Suk-Jae. Estimation of the minimum permeability coefficient in rats for perfusion-limited tissue distribution in whole-body physiologically-based pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics. 2017, 115: 1–17. PMID 28215648. S2CID 3455193. doi:10.1016/j.ejpb.2017.01.026.
Darwich, AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. Journal of Pharmacy and Pharmacology. 2012, 64 (7): 1008–1024. PMID 22686346. S2CID 46066754. doi:10.1111/j.2042-7158.2012.01538.x.
Bouvier d'Yvoire, M.; Prieto P.; Blaauboer B.J.; Bois F.; Boobis A.; Brochot C.; Coecke S.; Freidig A.; Gundert-Remy U.; Hartung T.; Jacobs M. N. Physiologically-based kinetic modelling (PBK modelling): meeting the 3Rs agenda - The report and recommendations of ECVAM Workshop 63a. Alternatives to Laboratory Animals. 2007, 35 (6): 661–671. PMID 18186671. S2CID 1247463. doi:10.1177/026119290703500606.|author9=和|last9=只需其一 (帮助)